IP Library Granted Patent US 7,578,809
Granted Patent B2
US 7,578,809 · App. 11/294,247 · Granted Aug 25, 2009

Surface modified viscoelastics for ocular surgery

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,578,809
App. No.
11/294,247
Granted
Aug 25, 2009
Kind
B2
Abstract

Disclosed are surface modified viscoelastics and methods of performing viscosurgery using polymer-containing irrigating solution to reduce cohesiveness of the viscoelastic agent at the interface, thereby improving its performance by reducing the occurrence of unintentional aspiration, especially in ocular surgery.

Claims (14)

1. A method of performing ophthalmic surgery comprising:

during capsulorhexis of a capsular bag, instilling a hyaluronate-based viscoelastic agent into the site of the surgery;

introducing a polymer-containing irrigating solution into the site of the surgery so that it makes contact with the viscoelastic agent along an interface;

permitting the irrigating solution to mix with the viscoelastic agent at the interface thereby reducing the cohesiveness of the viscoelastic agent along the interface; and

removing said viscoelastic before closing the capsular bag.

2. The method of claim 1 , wherein the hyaluronate-based viscoelastic is an aqueous solution of sodium hyaluronate having an average molecular weight greater than 750,000 Daltons and a concentration of from about 0.5% to about 3% by weight.

3. The method of claim 1 , wherein the polymer-containing irrigating solution contains a polymer having an average molecular weight of less than 500,000 Daltons, which polymer is selected from the group consisting of: HA, CS, polyacrylamide, HPMC, proteoglycans, collagen, methylcellulose, carboxymethyl cellulose, ethylcellulose, hydroxyethyl cellulose, polyvinylpyrrolidone, keratin, carrageenans, and pharmaceutically acceptable salts and combinations thereof.

4. The method of claim 3 , wherein the polymer-containing irrigating solution contains chondroitin sulfate at a concentration of from about 0.5% to about 7% by weight.

5. The method of claim 4 , wherein the concentration of the chondroitin sulfate in the irrigating solution is from about 2% to about 5% by weight and the chondroitin sulfate has an average molecular weight of from about 20,000 to about 80,000 Daltons.

6. The method of claim 3 , wherein the polymer-containing irrigating solution contains hydroxypropylmethyl cellulose at a concentration of from about 0.05% to about 5.0% by weight.

7. The method of claim 4 , wherein the concentration of the hydroxypropylmethyl cellulose in the irrigating solution is from about 0.1% to about 0.5% by weight and has an average molecular weight of from about 50,000 to about 200,000 Daltons.

8. The method of claim 1 , wherein said permitting the irrigating solution to mix with the viscoelastic agent at the interface comprises mixing using ultrasonic waves.

9. The method of claim 8 wherein said mixing takes place during phacoemulsification.

10. The method of claim 3 wherein the polymer-containing irrigating solution contains hydroxypropylmethyl cellulose at a concentration of from about 0.05% to about 5.0% by weight and chondroitin sulfate at a concentration of from about 0.5% to about 7% by weight.

Assignments (1)
CONFIRMATORY DEED OF ASSIGNMENT EFFECTIVE APRIL 8, 2019 Recorded Dec 10, 2019
From: NOVARTIS AG
To: ALCON INC.
Reel/Frame 051454/0788 →